載入...
17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2
INTRODUCTION: 17-allyamino-17-demethoxygeldanamycin (17-AAG), a small molecule inhibitor of Hsp90, is currently in clinical trials in breast cancer. However, 17-AAG treatment often results in inhibition of tumor growth rather than shrinkage, making detection of response a challenge. Magnetic resonan...
Na minha lista:
Main Authors: | , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2010
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3096977/ https://ncbi.nlm.nih.gov/pubmed/20946630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2729 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|